GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

We recently published a list of 10 Best Long Term Growth Stocks to Buy According to Billionaires. In this article, we are ...

Vertex Pharmaceuticals Inc. closed 8.54% short of its 52-week high of $519.88, which the company achieved on November 8th.

The stock's rise snapped a three-day losing streak.

On Wednesday, CrowdStrike announced an expansion of its partnership with Alphabet Inc 's GOOG +0.73% Get Free Report Google Cloud to enable end-to-end security for AI innovation with the company's ...

Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other stocks that Jim Cramer discusses. On Thursday, April 3 rd, the host of ...

The US$498 analyst price target for VRTX is 38% less than our estimate of fair value Does the April share price for Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) reflect what it's really worth?

Let's discuss whether Vertex Pharmaceuticals stock is a buy now ... the author and do not necessarily reflect those of Nasdaq, Inc. Founded in 1993 in Alexandria, VA., by brothers David and ...

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, ...